XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Unaudited Condensed Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Revenue $ 9,584 $ 9,260
Operating expenses:    
Costs of revenue (excluding amortization of purchased technology) 4,545 4,442
Selling, general and administrative expenses 9,626 6,179
Research and development expenses 634 513
Total operating expenses 14,805 11,134
Loss from operations (5,221) (1,874)
Interest expense 631 901
Other income, net 171 71
Loss from operations (5,681) (2,704)
Income tax benefit 118 0
Net loss (5,563) (2,704)
Accretion of redeemable convertible preferred stock 0 (2,114)
Net loss attributable to common stockholders (diluted) $ (5,563) $ (4,818)
Net loss per share:    
Net loss per share, basic and diluted (USD per share) $ (0.44) $ (76.46)
Weighted average shares:    
Weighted-average number of shares used to compute net loss per share, basic and diluted (in shares) 12,595,715 63,016